Molecular profiling of non-small-cell lung cancer patients with or without brain metastases included in the randomized SAFIR02-LUNG trial and association with intracranial outcome.
Mogenet A, Barlesi F, Besse B, Michiels S, Karimi M, Tran-Dien A, Girard N, Mazieres J, Audigier-Valette C, Locatelli-Sanchez M, Kamal M, Gestraud P, Hamza A, Jacquet A, Jimenez M, Yara S, Greillier L, Bertucci F, Planchard D, Soria JC, Bieche I, Tomasini P.
Mogenet A, et al. Among authors: yara s.
Lung Cancer. 2022 Jul;169:31-39. doi: 10.1016/j.lungcan.2022.05.004. Epub 2022 May 18.
Lung Cancer. 2022.
PMID: 35609409